SI1121127T1 - Oral pharmaceutical compositions containing buprenorphin - Google Patents
Oral pharmaceutical compositions containing buprenorphinInfo
- Publication number
- SI1121127T1 SI1121127T1 SI9930736T SI9930736T SI1121127T1 SI 1121127 T1 SI1121127 T1 SI 1121127T1 SI 9930736 T SI9930736 T SI 9930736T SI 9930736 T SI9930736 T SI 9930736T SI 1121127 T1 SI1121127 T1 SI 1121127T1
- Authority
- SI
- Slovenia
- Prior art keywords
- oral pharmaceutical
- pharmaceutical compositions
- compositions containing
- buprenorphin
- containing buprenorphin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT1998MI002222A IT1302682B1 (it) | 1998-10-16 | 1998-10-16 | Composizioni farmaceutiche orali contenenti buprenorfina |
EP99950690A EP1121127B1 (fr) | 1998-10-16 | 1999-10-11 | Compositions pharmaceutiques orales contenant buprenorphine |
PCT/EP1999/007595 WO2000023079A1 (fr) | 1998-10-16 | 1999-10-11 | Compositions pharmaceutiques orales contenant buprenorphine |
Publications (1)
Publication Number | Publication Date |
---|---|
SI1121127T1 true SI1121127T1 (en) | 2005-06-30 |
Family
ID=11380880
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI9930736T SI1121127T1 (en) | 1998-10-16 | 1999-10-11 | Oral pharmaceutical compositions containing buprenorphin |
Country Status (15)
Country | Link |
---|---|
US (1) | US6365596B1 (fr) |
EP (1) | EP1121127B1 (fr) |
JP (1) | JP2002527480A (fr) |
AT (1) | ATE287264T1 (fr) |
AU (1) | AU752449B2 (fr) |
CA (1) | CA2347195C (fr) |
DE (1) | DE69923336T2 (fr) |
DK (1) | DK1121127T3 (fr) |
ES (1) | ES2237165T3 (fr) |
HU (1) | HU226166B1 (fr) |
IT (1) | IT1302682B1 (fr) |
NZ (1) | NZ511085A (fr) |
PT (1) | PT1121127E (fr) |
SI (1) | SI1121127T1 (fr) |
WO (1) | WO2000023079A1 (fr) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002242705B2 (en) * | 2001-02-16 | 2006-08-24 | Gruenenthal Gmbh | Utilization of buprenorphine in urinary incontinence therapy |
US20140271788A1 (en) | 2013-03-15 | 2014-09-18 | Monosol Rx, Llc | Sublingual and buccal film compositions |
AU2005329255B2 (en) | 2004-04-15 | 2010-09-30 | Chiasma, Inc. | Compositions capable of facilitating penetration across a biological barrier |
DE602004017514D1 (de) * | 2004-06-02 | 2008-12-11 | Galephar M F | Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon |
NZ568313A (en) * | 2005-11-21 | 2011-11-25 | Schering Plough Ltd | Pharmaceutical compositions comprising buprenorphine |
EP1897543A1 (fr) | 2006-08-30 | 2008-03-12 | Euro-Celtique S.A. | Gaufre de buprénorphine pour la thérapie de substitution |
US20090270438A1 (en) * | 2006-10-18 | 2009-10-29 | Clive Booles | Novel compositions and formulations |
US20090082383A1 (en) * | 2007-09-26 | 2009-03-26 | Protia, Llc | Deuterium-enriched buprenorphine |
MX2011002836A (es) | 2008-09-17 | 2011-04-28 | Chiasma Inc | Composiciones farmaceúticas y métodos de administración relacionados. |
GB2469792A (en) * | 2009-04-23 | 2010-11-03 | Calvin John Ross | Oil-based pharmaceutical formulation for sublingual delivery |
HRP20211539T1 (hr) | 2011-09-19 | 2021-12-24 | Orexo Ab | Sublingvalne tablete otporne na zloupotrebu koje sadrže buprenorfin i nalokson |
US9918981B2 (en) | 2013-09-10 | 2018-03-20 | Insys Development Company, Inc. | Liquid buprenorphine formulations |
US9867818B2 (en) | 2013-09-10 | 2018-01-16 | Insys Development Company, Inc. | Sublingual buprenorphine spray |
US9839611B2 (en) | 2013-09-10 | 2017-12-12 | Insys Development Company, Inc. | Sublingual buprenorphine spray |
DK3043777T3 (da) | 2013-09-10 | 2020-07-20 | Fresh Cut Dev Llc | Sublingual buprenorphinspray |
US10617686B2 (en) | 2014-07-08 | 2020-04-14 | Hikma Pharmaceuticals Usa Inc. | Liquid naloxone spray |
WO2016007245A1 (fr) | 2014-07-08 | 2016-01-14 | Insys Pharma, Inc. | Aerosol sublingual de naloxone |
US10722510B2 (en) | 2014-07-08 | 2020-07-28 | Hikma Pharmaceuticals Usa Inc. | Liquid naloxone spray |
MA41462A (fr) | 2015-02-03 | 2021-05-12 | Chiasma Inc | Méthode de traitement de maladies |
ES2965836T3 (es) | 2018-01-22 | 2024-04-17 | Foresee Pharmaceuticals Co Ltd | Composición farmacéutica para administración de liberación mantenida de buprenorfina |
US11141457B1 (en) | 2020-12-28 | 2021-10-12 | Amryt Endo, Inc. | Oral octreotide therapy and contraceptive methods |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4605671A (en) * | 1984-09-28 | 1986-08-12 | American Home Products Corporation | Parenteral formulation |
JPH03275622A (ja) * | 1990-03-26 | 1991-12-06 | Teisan Seiyaku Kk | マレイン酸トリメブチンを含有する経口固形製剤 |
JPH08295637A (ja) * | 1995-04-27 | 1996-11-12 | Green Cross Corp:The | 口腔部局所投与剤 |
AU2059297A (en) * | 1996-03-12 | 1997-10-01 | Alza Corporation | Composition and dosage form comprising opioid antagonist |
JP3687025B2 (ja) * | 1998-06-04 | 2005-08-24 | 東和薬品株式会社 | 安定なマレイン酸エナラプリル錠剤 |
-
1998
- 1998-10-16 IT IT1998MI002222A patent/IT1302682B1/it active IP Right Grant
-
1999
- 1999-10-11 AT AT99950690T patent/ATE287264T1/de active
- 1999-10-11 US US09/807,216 patent/US6365596B1/en not_active Expired - Lifetime
- 1999-10-11 DK DK99950690T patent/DK1121127T3/da active
- 1999-10-11 PT PT99950690T patent/PT1121127E/pt unknown
- 1999-10-11 DE DE69923336T patent/DE69923336T2/de not_active Expired - Lifetime
- 1999-10-11 NZ NZ511085A patent/NZ511085A/xx not_active IP Right Cessation
- 1999-10-11 AU AU63371/99A patent/AU752449B2/en not_active Ceased
- 1999-10-11 SI SI9930736T patent/SI1121127T1/xx unknown
- 1999-10-11 WO PCT/EP1999/007595 patent/WO2000023079A1/fr active IP Right Grant
- 1999-10-11 ES ES99950690T patent/ES2237165T3/es not_active Expired - Lifetime
- 1999-10-11 EP EP99950690A patent/EP1121127B1/fr not_active Expired - Lifetime
- 1999-10-11 CA CA002347195A patent/CA2347195C/fr not_active Expired - Lifetime
- 1999-10-11 HU HU0103924A patent/HU226166B1/hu not_active IP Right Cessation
- 1999-10-11 JP JP2000576853A patent/JP2002527480A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US6365596B1 (en) | 2002-04-02 |
CA2347195A1 (fr) | 2000-04-27 |
NZ511085A (en) | 2002-10-25 |
DE69923336T2 (de) | 2005-05-25 |
JP2002527480A (ja) | 2002-08-27 |
ATE287264T1 (de) | 2005-02-15 |
AU752449B2 (en) | 2002-09-19 |
ES2237165T3 (es) | 2005-07-16 |
HU226166B1 (en) | 2008-05-28 |
ITMI982222A1 (it) | 2000-04-16 |
DE69923336D1 (de) | 2005-02-24 |
ITMI982222A0 (it) | 1998-10-16 |
AU6337199A (en) | 2000-05-08 |
PT1121127E (pt) | 2005-03-31 |
HUP0103924A3 (en) | 2003-05-28 |
EP1121127A1 (fr) | 2001-08-08 |
IT1302682B1 (it) | 2000-09-29 |
DK1121127T3 (da) | 2005-05-02 |
EP1121127B1 (fr) | 2005-01-19 |
CA2347195C (fr) | 2008-03-18 |
WO2000023079A1 (fr) | 2000-04-27 |
HUP0103924A2 (hu) | 2002-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI1121127T1 (en) | Oral pharmaceutical compositions containing buprenorphin | |
EP0960621A3 (fr) | Compositions pharmaceutiques comprenant du sildenafil | |
ZA200206905B (en) | Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same. | |
WO2000007979A3 (fr) | Composes et compositions pour l'administration de principes actifs | |
HK1043064A1 (en) | Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics | |
HUP0102676A3 (en) | Solid, quick dissolving pharmaceutical compositions containing cetrizine | |
BG66093B1 (bg) | Състави с контролирано освобождаване, съдържащи нимесулид | |
HUP0401638A3 (en) | Thiopene-amides, thiazolesulfonamides as antineoplastic agents, and pharmaceutical composition containing the same | |
CA2366679A1 (fr) | Composition pharmaceutique orale stabilisee contenant de l'iodure et de l'iodate et procede associe | |
HUP0400832A3 (en) | New amidoalkyl-piperidine and amidoalkyl-piperazine derivatives, and pharmaceutical compositions containing such derivatives as active ingredients | |
ZA200410211B (en) | Quinuclidine derivatives and pharmaceutical compositions containing the same. | |
HK1045113A1 (zh) | 給予固定的曲馬朵和雙氯酚酸組合的口服給藥形式 | |
PL348419A1 (en) | Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredient | |
EP2308479A3 (fr) | Composés et compositions pour la distribution d'agents actifs | |
AU2002309038A1 (en) | Compositions for transmucosal administration containing coenzyme Q as the active ingredient | |
HUP0103431A3 (en) | Pharmaceutical, oral compositions containing 5-ht4 agonists or antagonists as active agent | |
AU5892399A (en) | 1, 2, 4-triazole-3-thione compounds | |
ZA200110150B (en) | Streptogramin derivatives, preparation and compositions containing them. | |
HUP0303673A3 (en) | Piperidine derivatives and pharmaceutical compositions containing these derivatives as the active ingredient | |
AU4317500A (en) | Antibiral compositions containing phorbol derivatives as the main active ingredient | |
EP1273301A3 (fr) | Préparations pharmaceutiques comprenant des principes actifs susceptibles d'administration illicite | |
IL154986A0 (en) | Triazolo-epothilone derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof | |
WO2002004012A8 (fr) | Composition pharmaceutique anhydre de vancomycine a usage topique | |
AU2882699A (en) | Stabilizing composition for pharmaceutical dosage forms | |
HUP0303714A3 (en) | Pharmaceutical compositions for dementia remedies containing 2-aryl-8-oxodihydropurine derivatives as the active ingredient |